What is the catalog number for AKR1B1 Rabbit Polyclonal Antibody?

The catalog number for AKR1B1 Rabbit Polyclonal Antibody is orb381037.

What sizes are available for AKR1B1 Rabbit Polyclonal Antibody?

AKR1B1 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is AKR1B1 Rabbit Polyclonal Antibody in stock?

AKR1B1 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

AKR1B1 Rabbit Polyclonal Antibody

Product Specifications

Product Name Alternative

Aldose reductase; AR; 1.1.1.21; Aldehyde reductase; Aldo-keto reductase family 1 member B1; AKR1B1; ALDR1

UniProt

P15121

Reactivity

Human, Mouse, Rat

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

E. coli-derived human AKR1B1 recombinant protein (Position: L228-F316) . Human AKR1B1 shares 87.5% amino acid (aa) sequence identity with both mouse and rat AKR1B1.

Target

Aldo-keto reductase family 1 member B1

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cancer Biology, Metabolism Research, Signal Transduction

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Human, Mouse, Rat Immunohistochemistry (Paraffin-embedded Section), 0.5-1μg/ml, Human, Rat Flow Cytometry (Fixed), 1-3μg/1x10^6 cells, Human

Form

Lyophilized

Molecular Weight

36 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

FC, IHC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.